WELCOME
Hi there! I'm James Issa, a biology undergraduate at UNC Chapel Hill
I’m thrilled to invite you to explore my experiences, career goals, and about who I am. Feel free to contact me at anytime. I am more than ecstatic to delve further in my field.
ABOUT ME
"Always be a first-rate version of yourself, instead of a second-rate version of somebody else."
—Judy Garland
I am 20 years of age originally from Aleppo, Syria. I was raised in Charlotte, NC with my loving family of 4
I am currently a member of the 2021-22 Level The Playing Field Cohort
I love playing the piano, exploring nature, and maintaining a healthy lifestyle
 |  |  |
|---|
EXPERIENCES & EDUCATION
My Accomplishments!
UNC CHAPEL HILL UNDERGRADUATE
I am currently pursuing admission to medical school!
2019 - 2023
MEMBER OF LEVEL THE PLAYING FIELD
2021 - Present
LTPF is an organization with an astonishing support group with a purpose of placing minority students into successful positions and opportunities. Being a member of this cohort has enhanced my professional, networking, and interpersonal skills.
SHADOWING
2017 & 2021
Shadowed oncologist and hematologist Dr. Muslimani at the Levine Cancer Institute with Atrium Health
Shadowed cardiologist Dr. Karam at the CAMC Beckley Clinic
CAROLINA FOR THE KIDS OFFICER
Provide families with emotional, medical, and financial support for the patients and families served by UNC Children’s Hospital
2021 - Present
CHAPLAIN OF ALPHA TAU OMEGA FRATERNITY
As a member of the executive board, decisions were made on behalf of the 91 current members with an annual budget of ~$350,000. We also achieved the 3rd highest aggregate GPA amongst all other IFC fraternities.
2020 - 2021
CAREER GOALS
I would love to combine my experiences working around kids with my shadowing experiences. As of now, I am aspiring to become a pediatric hematologist or cardiologist!
I am thrilled to have the opportunity to work alongside Dr. Savoldo in Summer of 2022: I will be aiding in the redirecting of T-cells to better target tumors for certain hematological malignancies, such as leukemia and CD19+.